Related Experiment Video
Updated: Jan 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway
Danna Zheng1,2,3,4, Mei Tao2,3,4, Xudong Liang2,3,4
1Zhejiang Chinese Medical University, Zhejiang, PR China.
Background And Aims:
Autophagy has been found to be involved in podocyte injury, which is a key factor in the progression of diabetic kidney disease (DKD). p66Shc is an important protein adaptor that regulates production of reactive oxygen species (ROS) and induction of apoptosis, and is a novel biomarker for oxidative damage of renal tubules. Our preliminary studies showed that p66Shc expression in podocytes of DKD patients is increased, while autophagic flux and podocyte number is decreased in DKD patients. The mechanism by which p66Shc may regulate podocyte autophagy and injury remains unknown. The present study aimed to investigate the molecular function of p66Shc under high glucose condition and its possible therapeutic utility in DKD.
Methods:
We histologically evaluated kidney injury in a streptozocin (STZ)-induced mouse model of diabetes using HE, PAS, PASM, and Masson staining and assessed glomerular structure by transmission electron microscopy. The apoptosis rate of high glucose-treated podocytes was assessed by TUNEL and Annexin V/PI staining. Markers of podocyte autophagy were measured by immunofluorescence and western blotting. DHE/ET fluorescence quantification was used for ROS detection and quantification.
Results:
Urine creatinine, serum creatinine, urinary microalbumin, and p66Shc expression were significantly increased in STZ-induced diabetic mice. Cultured MPC5 podocytes subjected to high glucose showed reduced viability, and p66Shc overexpression further accelerated apoptosis. p66Shc knockdown enhanced HG-induced autophagy, while p66Shc overexpression reduced the expression of PTEN and increased the expression of mTOR and phospho-mTOR. LC3 protein expression was higher in cells with p66Shc knockdown, indicating that activation of p66Shc inhibits podocyte autophagy. DAPT, an inhibitor of the Notch pathway, downregulated the expression of p66Shc.
Conclusion:
These findings indicate that p66Shc inhibits podocyte autophagy and induces apoptosis through the Notch -PTEN-PI3K/Akt/ mTOR signaling pathway in high glucose environment, providing novel evidence for its potential role in DKD treatment.
Insights
p66Shc protein inhibits autophagy and promotes apoptosis in kidney podocytes, contributing to diabetic kidney disease (DKD). Targeting p66Shc may offer a new therapeutic strategy for DKD.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Diabetic kidney disease (DKD) involves podocyte injury, with autophagy playing a crucial role.
- p66Shc is implicated in oxidative stress and apoptosis, and its expression is elevated in DKD podocytes.
- The precise mechanism linking p66Shc to podocyte autophagy and injury in DKD is not fully understood.
Purpose of the Study:
- To investigate the molecular function of p66Shc in podocytes under high glucose conditions.
- To explore the potential of targeting p66Shc as a therapeutic strategy for DKD.
Main Methods:
- Utilized a streptozotocin-induced mouse model of diabetes.
- Assessed kidney injury using histological staining and electron microscopy.
- Evaluated podocyte apoptosis and autophagy markers via TUNEL, Annexin V/PI, immunofluorescence, and western blotting.
- Measured reactive oxygen species (ROS) levels using DHE/ET fluorescence.
Main Results:
- Diabetic mice exhibited increased markers of kidney injury and p66Shc expression.
- High glucose reduced podocyte viability; p66Shc overexpression exacerbated apoptosis.
- p66Shc knockdown enhanced autophagy, while overexpression inhibited it by downregulating PTEN and upregulating mTOR signaling.
- Inhibition of the Notch pathway with DAPT reduced p66Shc expression.
Conclusions:
- p66Shc inhibits podocyte autophagy and induces apoptosis via the Notch-PTEN-PI3K/Akt/mTOR pathway in high glucose conditions.
- These findings highlight p66Shc as a potential therapeutic target for DKD.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway
Cell Specific Gene Expression

